Questionnaire Survey on the Current Situation and Experience in Prevention and Control Measures at Urology Clinics During the COVID-19 Epidemic in China

COVID-19, the coronavirus disease 2019; SARS-CoV-2, the coronavirus 2; ACE2, angiotensin converting enzyme 2; S protein, spiked glycoprotein; TMPRSS2, transmembrane serine protease 2; WHO, World Health Organization.

Purpose: Although the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2, has been viably controlled in China, a new normal in healthcare strategies has become standard in China and worldwide. We conducted a questionnaire study to disseminate the experience from China in terms of urology outpatient prevention and control measures under standardized prevention policies against COVID-19.

Participants and Methods: From May 3, 2020 to June 25, 2020, we conducted an anonymous cross-sectional questionnaire study, focused on the status of and experiences with outpatient urology prevention and control measures during the COVID-19 pandemic. The targeted respondents were urologists in mainland China, covering all levels of hospitals and clinics.

Results: A total of 216 (97%) valid responses were collected. We found that 183 (85%) respondents were from outside of Hubei province in China. One-hundred-and-fifty-eight (73%) respondents believed that SARS-CoV-2 could be detected in urine, and that protection against urine exposure was needed. Over 80% of respondents recommended WeChat application or similar online video meetings for virtual outpatient consultations. The suggested flowcharts and recommendations to prevent new cases were easy to understand and approved by most physicians, which could provide reference for outpatient prevention and control. We still need to make adequate preparations under the new normal of the COVID-19 Epidemic, especially for those suspected of being infected.

Conclusions: Although the scientific validation of the questionnaire is limited, it provides a first snapshot of the experiences relating to the prevention and control measures in urology clinics in China, and can inform future policies in this field.

Introduction

The coronavirus disease 2019 (COVID-19) began at the end of 2019 and has rapidly become an ongoing global pandemic. The COVID-19 pandemic has major ramifications for global health and the economy (1, 2). To control the spread of the epidemic, the Chinese Government and people have put forth unremitting efforts, which proved to be effective so far (3). COVID-19 prevention and control measures have become standard in Chinese healthcare providers practice due to the difficult situation of both an ongoing global pandemic and sporadic domestic epidemics. The recommended preventive measures include social distancing, wearing face masks, hand washing, disinfecting surfaces, and isolation for people exposed (4). The COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highly variable symptoms ranging from almost none to life-threateningly severe (5, 6). It has been confirmed that SARS-CoV-2 can be transmitted by droplets and close contact. Additionally, SARS-CoV-2 is detectable in urine, as it becomes concentrated in the urinary system and in fecal matter, remaining positive in the excretion of some patients who have recovered from COVID-19 (7). A systematic review of COVID-19 and its potential urological manifestations revealed that 5.74% urine samples from COVID-19 patients were positive for viral RNA, but the duration of viral shedding in urine was unknown (8). A global survey on the impact of COVID-19 on urological services showed that 41% of respondents reported that their hospital staff had been diagnosed with COVID-19 infection (2). To this end, we conducted a national questionnaire survey to disseminate the Chinese urology outpatient experience with prevention and control measures under the new normality of COVID-19. We hope our results and experiences can help guide our future outpatient work, and can also help international counterparts with anti-COVID-19 efforts in urological outpatient practice.

Participants and Methods

Study Design and Population

To best represent the current situation in prevention and control measures in urology outpatient practice in China, during the COVID-19 pandemic, the targeted respondents were urologists in mainland China, covering five levels of hospitals and clinics from 22 provinces, two autonomous regions and four municipalities (Table 1). We conducted an anonymous cross-sectional questionnaire study targeting domestic urologists in China. Questionnaires were distributed by email and the WeChat application from May 3, 2020 to June 25, 2020. WeChat is one of most popular social applications, with over one billion users and over 400 million active users daily.

TABLE 1

Table 1. Demographics of survey respondents.

The Design and Contents of the Questionnaire

The questionnaire comprised a total of 34 questions, with single-choice and multiple-choice response items. The content of the questionnaire was mainly based on the seventh edition of the “Chinese Novel Coronavirus Diagnosis and Treatment Guide for Pneumonia,” which was relatively authoritative in China at the beginning of the COVID-19 outbreak (9). The questionnaire was also referred to published scientific articles of the latest research on COVID-19 at the beginning of the COVID-19 outbreak (10–12). Considering that our understanding of this disease was limited, most of the questions designed were in non-scale form. Although the questionnaires have had passed the reliability and validity test according to The Statistical Program for Social Sciences software analysis, the scientific evidence upon which the survey was based was still limited. The entire questionnaire is presented in Supplementary Tables 1–6.

Data Analysis

We randomly distributed 250 questionnaires via email and the WeChat application to urologists who had “urology” listed as their specialty. A total of 222 (89%) questionnaires were returned. The number of 250 questionnaires was expected to provide adequate data with appropriate statistical power and workload with optimized representative domestic professional scale. After excluding questionnaires from non-urologist and incomplete responses, 216 (97%) responses were confirmed as valid. For each question in the questionnaire, the number of participants and the corresponding percentage was calculated for each of the response items.

Results

Demographics

The results of this questionnaire represented the views of physicians mainly outside Hubei Province in China (Table 1). The respondents comprised of urological doctors working at various hospital levels, from senior urologists to junior urological specialists. Physicians from various provinces of China completed the questionnaire, including physicians from the Hubei province and its capital city, Wuhan, where the first reported and confirmed COVID-19 cluster cases were location (9).

SARS-CoV-2 and the Genitourinary System

Most respondents indicated that they believed that SARS-CoV-2 could be detected in urine, while only some believed that SARS-CoV-2 was detectable in semen (Table 2.1.1,2.1.2). Regarding transmission methods, only 35 (16%) respondents believed that SARS-CoV-2 could be spread through the urogenital system (Table 2.1.3). Over 152 (70%) respondents believed that the kidney, bladder, and testes could be affected by SARS-CoV-2 (Table 2.1.4).

TABLE 2

Table 2. The main results of the questionnaire survey.

Impact of COVID-19 on Outpatient Clinics

One-hundred-and-seventy-five (81%) respondents recommended WeChat or similar internet video meetings as virtual outpatient consultations during the epidemic (Table 2.2.1). One-hundred-and-eighteen (55%) respondents believed that these virtual visits were better than routine service for the prevention of new COVID-19 cases (Table 2.2.2).

Impact of COVID-19 on Psychological Status

According to the results of the questionnaire, both the respondents and their patients have been significantly affected by the COVID-19 epidemic, mainly in terms of weariness and anxiety (Table 2.3.1, 2.3.2). One-hundred-and-seventy-eight (82%) respondents believed that appropriate psychological consultations are essential for supporting their outpatient practice (Table 2.3.4). In addition, 110 (51%) respondents indicated that their patients experienced significant frequent urination symptoms during the epidemic (Table 2.3.3). In addition to medical issues, changes in mental health status may affect patients' lower urinary tract symptoms, especially in terms of frequency.

Experience With COVID-19 Screening in Outpatient Clinics

According to the results of the questionnaire, epidemiological history and chest computed tomography (CT) examination were considered the most important screening methods (Table 2.4.1). The majority of respondents used the following preventive measures in their outpatient practice: wearing a surgical mask [199(93%)], wearing gloves and performing hand sterilization [149(69%)], and environmental disinfection [149(69%)] (Table 2.4.2). The majority of respondents believed that catheterization [135(63%)] and intravesical installation [111(51%)] were the main procedures requiring precautions to be taken during outpatient treatments (Table 2.4.3). During outpatient surgery, cystoscopy, ureteral stent removal or replacement, and extracorporeal shock wave lithotripsy were the primary concerns (Table 2.4.4). In these procedures, the operator is likely to be in close contact with patients and the patients' urine.

The flowcharts we provided were overwhelmingly recognized and approved by the respondents, and included an outpatient procedures flowchart for screening patients with COVID-19 (Figure 1), a flowchart for wearing protection in outpatient treatment rooms (Figure 2), a protection flowchart for wearing protection in outpatient operating rooms (Figure 3), and a table of recommendations for protective options in urological outpatient clinics (Table 3).

FIGURE 1

Figure 1. Outpatient procedures flowchart for screening patients with COVID-19.

FIGURE 2

Figure 2. Flowchart for wearing protection in outpatient treatment rooms.

FIGURE 3

Figure 3. Flowchart for wearing protection in outpatient operating rooms.

TABLE 3

Table 3. Recommendations for protective options in urological outpatient clinics.

Experience With Patients With a History of COVID-19 in Outpatient Clinics

When treating patients who have recovered from COVID-19, the majority of respondents stated that it is still necessary to examine such patients separately, and that their medical waste should be separated in outpatient clinics (Table 2.5.1). Most respondents recommended testicular and semen screening for fertility in men of reproductive age who have recovered from COVID-19 (Table 2.5.2).

Discussion

SARS-CoV-2 and the Genitourinary System

COVID-19 has been found to infect human respiratory epithelial cells via a molecular mechanism of spiked glycoprotein (S protein) interaction with human angiotensin converting enzyme 2 (ACE2) receptor, causing lung tissue damage (13). Transmembrane serine protease 2 (TMPRSS2) appears to be the progenitor of the S protein that enhances ACE2 receptor-mediated viral entry (14). Utilizing the latest single-cell RNA sequencing data, a research team from Shanghai Jiaotong University analyzed ACE2 receptor expression in relevant organs and cell types of major human physiological systems and found that the heart, esophagus, kidney, bladder, and ileum all have ACE2 receptor expression similar to or higher than that in alveoli (15). Additionally, a research team from Suzhou Hospital affiliated with Nanjing Medical University analyzed the expression of ACE2 receptor in different human organs using existing datasets and found that ACE2 receptor is highly expressed in renal tubular cells, testicular mesangial cells, and seminiferous tubular cells of the testis (16). The above findings imply that, at the RNA level, the kidneys, bladder, and testes of the urinary system are potential target organs for SARS-CoV-2, concordant with the beliefs of the respondents in the current study.

Furthermore, Guan et al. (10) confirmed that SARS-CoV-2 can be detected in excreta such as urine and feces. Consequently, whether sexual contact is one of the potential routes of SARS-CoV-2 transmission has been raised (17). Li et al. (18) found that SARS-CoV-2 was detected in the semen of 6 out of 38 patients diagnosed with COVID-19. Interestingly, Pan et al. (19) did not detect SARS-CoV-2 in the semen of 34 patients diagnosed with COVID-19 in Wuhan, China. Therefore, we suspect that the detectability in semen might be related to viral load, virus survival time, and the blood-testis barrier. Currently, there is no direct evidence of this mode of transmission. Accordingly, our questionnaire study found that less than half of respondents believed that SARS-CoV-2 is detectable in semen. However, Corman et al. (20) suggested that RNAemia is not equivalent to infectiousness. Additionally, there is a lack of direct evidence that SARS-CoV-2 can be transmitted by blood transfusion (21).

Acute kidney injury has been reported to be a common complication among hospitalized patients with COVID-19 (22). It is considered a marker of disease severity and a negative prognostic factor for survival in patients with COVID-19, based on experience in the United States (23). It was still unclear whether SARS-CoV-2 directly affect the kidney, although renal histopathological analyses of 26 Chinese COVID-19 patients suggested varying degrees of acute tubular injury (24). The prognosis of COVID-19 patients with acute kidney injury was poor, especially those patients with other underlying diseases (25, 26).

Impact of COVID-19 on Outpatient Clinics

According to the local public health department advice, most people chose to stay at home during the epidemic, especially at the beginning of the outbreak. In order to effectively maintain close contact and communication with patients, physicians and patients stayed in touch via WeChat, video calls, and telephone. A global internet survey revealed that the use of telemedicine related devices by urologists nearly tripled during the COVID-19 epidemic (27). This was indeed a pragmatic approach to reducing the risk of transmission, and was worth promoting. Most patients have already benefited from virtual outpatient consultations. However, treatment during the epidemic was compromised for patients with primary symptoms of urinary tumors and post-operative patients with urinary tumors, which would affect their survival over time.

Impact of COVID-19 on Psychological Status

Psychological factors, such as psychological stress and depression, clearly affect the human endocrine and immune systems (28). Psychological factors can cause metabolic dysregulation of neurotransmitters, such as monoamines and peptides, resulting in hypothalamic-pituitary-gonadal axis and hypothalamic-pituitary-adrenal axis dysfunction, which in turn affects the endocrine and immune reproductive system functions in human, resulting in reproductive dysfunction (29). The psychological states of stress and anxiety experienced by patients with chronic prostatitis are considered an important factor in the development or exacerbation of inflammation. A global survey of psychological impact among surgical providers showed that the COVID-19 pandemic may have a mental health legacy outlasting its course (30). Based on the results of our questionnaire study, the psychological status of both clinical staff and patients have been impacted by the epidemic to varying degrees, and both clinical staff and patients need opportune mental help. Above all else, patients should be effectively managed to obtain accurate healthcare information from the World Health Organization (WHO) internationally and the domestic National Health Care Commission (31, 32), so as to not be impacted by rumors and to not spread inaccurate data. These recommendations can still benefit those patients who need assistance during the COVID-19 pandemic.

Experience With COVID-19 Screening in Outpatient Clinics

With the continuous importation of COVID-19 cases from outside the country (33–35), and the increasingly subtle epidemiological history and atypical clinical manifestations (36), additional cases will appear in outpatient clinics for two or three generations (37). The performance of PCR-based diagnostic depended upon several factors such as sample type, different stage of infection in patient, the skill of the collection, and the quality and consistency of the PCR-based diagnosis assays being used (38, 39). Therefore, the performance of PCR-based diagnosis may be false negative, resulting in clinical underdiagnosis. Our survey results showed that CT and epidemiological history are accepted by the majority of respondents. CT examination is not only convenient and quick, but also provides strong evidence, and is especially suitable for emergency and scheduled surgeries in inpatients and outpatients with suspected COVID-19. Chen et al. (40) considered hand sanitization as one of the most important measures to prevent epidemic-associated viral infections. Additionally, the (WHO) recommends hand decontamination by rubbing the hands with alcohol, for example, after glove removal (41). The above recommendations were generally endorsed by the respondents in the current study.

Aerosols are common in medical work environments, such as with nebulized inhalation and tracheal intubation, and samples of blood, urine, feces, etc. SARS-CoV-2 can be detected in aerosols for up to 3 h, on copper surfaces for up to 4 h, on cardboard for up to 24 h, and on plastics and stainless steel for up to 2 to 3 days (42). Guo et al. (43) analyzed workspaces in Wuhan Vulcan Hill Hospital (in the epidemic area) and found that SARS-CoV-2 was widely distributed in the air and on the surface of objects in the intensive care unit and general COVID-19 ward. Since the outpatient clinic room is an enclosed environment, staff and patients are susceptible to SARS-CoV-2 transmission by aerosols. In particular, physicians should raise the level of protection when contacting suspected or confirmed patients with COVID-19.

Xu et al. (44) found that some patients had a positive rectal swab even after a negative nasopharyngeal swab test. Therefore, when conducting digital rectal examinations in patients with suspected COVID-19 or recovering from COVID-19, it is recommended to do so gently and to wear double gloves, minimizing the occurrence of glove breakage. Some cases of post-operative death due to nosocomial infection of COVID-19 had been reported (45). Some studies had shown that pre-operative CT examination and nucleic acid testing are helpful to reduce the incidence of postoperative COVID-19 (12, 46). Electrosurgical and energetic devices should be used appropriately during outpatient procedures to promptly aspirate smoke and reduce aerosol injuries. During outpatient treatments or surgical procedures, physicians should use disposable instruments and other items as much as possible. For patients with suspected or confirmed COVID-19, devices used during the procedure, such as disposable instruments, sharp boxes, and catheters, should be clearly identified with a confirmed or suspected COVID-19 label and removed via the special infection channel (45, 46). Furthermore, Kuang et al. (46) suggested that clinical staff disinfect their soles before stepping out of the room of a patient with COVID-19.

The included flowcharts were standard procedures in our hospital, mainly based on the diagnosis and treatment protocol and technical guidelines of COVID-19 in China (9, 47). Although not officially standard, they were simple and easy to understand and could provide reference for outpatient protection work. If occupational exposure occurs during the above process, prompt symptomatic treatment is required. If body fluid exposure occurs, it is recommended that the operator should immediately remove the contaminant and repeatedly apply a large amount of saline rinse or 0.05% iodine for skin or mucous membrane rinsing and disinfection, respectively. In cases of blood exposure, the operator should gently squeeze the blood near the wound from the proximal end to the distal end, squeezing out as much blood as possible at the wound, followed by a rinse with flowing water, and disinfection with 75% alcohol or 0.5% iodine (12, 41). In the event of respiratory exposure, it is recommended to gently wipe the nasal cavity with a cotton ball containing 75% alcohol, followed by flushing with plenty of normal saline and medical isolation.

Experience With Patients With a History of COVID-19 in Outpatient Clinics

Ma et al. (48) found significant changes in sex hormone levels in male patients with COVID-19 of reproductive age. Changes in sex hormones may affect future fertility (49). Our questionnaire recommended testicular and semen screening for fertility in men of reproductive age who have recovered from COVID-19. It may also provide new evidence on whether SARS-CoV-2 attacks the testes in the future. The majority of respondents in the current study indicated that outpatient urological control measures still need to be continued in the future in response to the domestic and international situation of the ongoing pandemic.

Limitations

The survey and experiences were achieved from one specialty (urology) in one country (China), therefore the main results and conclusions may not apply to different settings or other regions. Considering that our knowledge of the disease was limited at the time of questionnaire formulation, this questionnaire study had some limitations. On some questions we limited the answer options, so that respondents might not be able to respond completely objectively. There were even more uncertainties when designing the questionnaire and responses, such as whether SARS-CoV-2 could be detected in semen and the possibility of transmission of SARS-CoV-2 through urine or semen. In addition, there were certain limitations in the sample size and survey distribution method of the questionnaire that may have affected the final dataset.

Conclusions

Through the questionnaire survey, we learned about the current situation, experience and measures of epidemic prevention and control of COVID-19 in urology outpatient department in China. Although the scientific evidence of the survey was low, it could still provide us with a lot of helpful measure. The majority of physicians believed that SARS-CoV-2 could be detected in urine, and that protection against urine exposure was needed. These suggested flowcharts and recommendations to prevent new cases were accepted by most urologists in this survey. In terms of protective measures, it is still recommended to wear protection, especially when in contact with suspected samples during outpatient practice under the new normal of COVID-19.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.

Ethics Statement

The studies involving human participants were reviewed and approved by The First Affiliated Hospital of Wenzhou Medical University and Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, China. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

Author Contributions

H-HJ and MW had roles in conception and design. X-LZ, M-HJ, W-LL, J-HL, and Z-LS had roles in the questionnaire design, data collection, data analysis, data interpretation, and literature search. H-HJ and X-LZ had roles in writing of the manuscript. H-HJ, X-LZ, and MW contributed to the critical revision and data interpretation of the manuscript. MW had roles in supervision. All authors contributed to data acquisition, analysis, and interpretation, and reviewed and approved the final version.

Funding

This questionnaire study was supported by Zhejiang Provincial Natural Science Foundation of China (No. WY20H050001), the National Natural Science Foundation of China (No. 81670695), Zhejiang Provincial Medical and Health Technology Program Projects of China (Nos. 2018PY031, 2018KY512, and 2019KY102), and Wenzhou Science and Technology Bureau Project (No. 2018Y0144). These funds were used in the design of the study, data collection, and personnel support.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We thank all of the urological specialists and patients who shared their data and related information in the questionnaire.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2021.670889/full#supplementary-material

References

1. Hertz-Palmor N, Moore TM, Gothelf D, DiDomenico GE, Dekel I, Greenberg DM, et al. Association among income loss, fina strain and depressive symptoms during COVID-19: evidence from longitudinal studies. J Affect Disord. (2021) 291:1–8. doi: 10.1016/j04.054

CrossRef Full Text | Google Scholar

2. Teoh JY-C, Ong WLK, Gonzalez-Padilla D, Castellani D, Dubin JM, Esperto F, et al. A Global survey on the impact of COVID-19 on urological services. Eur Urol. (2020) 78:265–75. doi: 10.1016/j.eururo.2020.05.025

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Ye Q, Wang B, Mao J, Fu J, Shang S, Shu Q, et al. Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol. (2020) 92:755–69. doi: 10.1002/jmv.25813

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Saeed H, Osama H, Madney YM, Harb HS, Abdelrahman MA, Ehrhardt C, et al. COVID-19; current situation and recommended interventions. Int J Clin Pract. (2021) 75:e13886. doi: 10.1111/ijcp.13886

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. (2021) 54:12–6. doi: 10.1016/j.jmii.2020.05.001

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054–62. doi: 10.1016/S0140-6736(20)30566-3

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. (2020) 5:434–5. doi: 10.1016/S2468-1253(20)30083-2

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Chan VW-S, Chiu PK-F, Yee C-H, Yuan Y, Ng C-F, Teoh JY-C. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World J Urol. (2020) 27:1–12. doi: 10.1007/s00345-020-03246-4

PubMed Abstract | CrossRef Full Text | Google Scholar

9. National Health Commission of the People's Republic of China. Medical Administration and Medical Authority (2020). Available online at: http://www.nhc.gov.cn/xcs/fkdt/202003/a31191442e29474b98bfed5579d5af95.shtml (accessed March 4, 2020). [in Chinese]

10. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of coronavirus disease 2019 in China. N Engl J Med. (2020) 382:1708–20. doi: 10.1056/NEJMoa2002032

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. (2020) 382:1199–207. doi: 10.1056/NEJMoa2001316

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Yu X, Li F, Yang F, Qu XL, Guo XL, Wang SG, et al. Suggestions for prevention and control of COVID-19 in urological surgery. Zhonghua Mi Niao Za Zhi. (2020) 41:E001.doi: 10.3760/cma.j.issn.1000-6702.2020.0001

CrossRef Full Text

13. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. (2020) 27:325–8. doi: 10.1016/j.chom.2020.02.001

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271–80. doi: 10.1016/j.cell.2020.02.052

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. (2020) 14:185–92. doi: 10.1007/s11684-020-0754-0

PubMed Abstract | CrossRef Full Text

16. Fan C, Li K, Ding Y, Lu W, Wang J. ACE2 expression in kidney and testis may cause kidney and testis infection in covid-19 patients. Front Med. (2020) 7:563893. doi: 10.3389/fmed.2020.563893

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Patrì A, Gallo L, Guarino M, Fabbrocini G. Sexual transmission of SARS-CoV-2: a new possible route of infection? J Am Acad Dermatol. (2020) 82:e227. doi: 10.1016/j.jaad.2020.03.098

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. (2020) 3:e208292. doi: 10.1001/jamanetworkopen.2020.8292

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Pan F, Xiao X, Guo J, Song Y, Li H, Patel D, et al. No evidence of SARS-CoV-2 in semen of males recovering from COVID-19. Fertil Steril. (2020) 113:1135–9. doi: 10.1016/j.fertnstert.2020.04.024

PubMed Abstract | CrossRef Full Text

20. Corman V, Rabenau H, Adams O, Oberle D, Funk M, Keller-Stanislawski B, et al. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission. Transfusion. (2020) 60:1119–22. doi: 10.1101/2020.03.29.20039529

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Cappy P, Candotti D, Sauvage V, Lucas Q, Boizeau L, Gomez J, et al. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation. Blood. (2020) 136:1888–91. doi: 10.1182/blood.2020008230

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, et al. Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis. Kidney Int Rep. (2020) 5:1149–60. doi: 10.1016/j.ekir.2020.06.013

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. (2020) 323:2052–9. doi: 10.1001/jama.2020.6775

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, et al. Renal histopathological analysis of postmortem findings of patients with COVID-19 in China. Kidney Int. (2020) 98:219–27. doi: 10.1016/j.kint.2020.04.003

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Shaikh S, Matzumura Umemoto G, Vijayan A. Management of acute kidney injury in coronavirus disease 2019. Adv Chronic Kidney Dis. (2020) 27:377–82. doi: 10.1053/j.ackd.2020.08.002

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Teoh JY-C, Yip TC-F, Lui GC-Y, Wong VW-S, Chow VC-Y, Ho TH-Y, et al. Risks of AKI and major adverse clinical outcomes in patients with severe acute respiratory syndrome or coronavirus disease 2019. J Am Soc Nephrol. (2021) 32:961. doi: 10.1681/ASN.2020071097

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Dubin JM, Wyant WA, Balaji NC, Ong WLK, Kettache RH, Haffaf M, et al. Telemedicine usage among urologists during the COVID-19 pandemic: cross-sectional study. J Med Internet Res. (2020) 22:e21875. doi: 10.2196/21875

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Kaye J, Morton J, Bowcutt M, Maupin D. Stress, depression, and psychoneuroimmunology. J Neurosci Nurs. (2000) 32:93–100. doi: 10.1097/01376517-200004000-00005

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Schenker J, Meirow D, Schenker E. Stress and human reproduction. Eur J Obstet Gynecol Reprod Biol. (1992) 45:1–8. doi: 10.1016/0028-2243(92)90186-3

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Tan YQ, Wang Z, Yap QV, Chan YH, Ho RC, Hamid ARAH, et al. Psychological health of surgeons in a time of COVID-19: a global survey. Ann Surg. (2021). doi: 10.1097/sla.0000000000004775

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. (2020) 17:1729. doi: 10.3390/ijerph17051729

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. (2020) 33:e100213. doi: 10.1136/gpsych-2020-100213

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Fang QW, Gong XH, Xiao WJ, Jin BH, Yu X, Cui P, et al. [Epidemiological characteristics and measures of prevention and control of imported COVID-19 cases in early phase in Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi. (2020) 41:2034–9. doi: 10.3760/cma.j.cn112338-20200413-00566

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Zhen RN, Huang Y, Li YL, Zhou S, Chen YY, Qin FJ, et al. [Epidemiological characteristics of imported COVID-19 cases in Guangzhou]. (2020) 41:1786–90. doi: 10.3760/cma.j.cn112338-20200413-00569

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Pan J, Tian J, Xiong H, Liu Z, Yao Y, Wang Y, et al. Risk assessment and evaluation of China's policy to prevent COVID-19 cases imported by plane. PLoS Negl Trop Dis. (2020) 14:e0008908. doi: 10.1371/journal.pntd.0008908

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Han D, Li R, Han Y, Zhang R, Li J. COVID-19: insight into the asymptomatic SARS-COV-2 infection and transmission. Int J Biol Sci. (2020) 16:2803–11. doi: 10.7150/ijbs.48991

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Zhang X, Wang H, Wang Y, Lei Y, Xu K, Zhang J, et al. Epidemiological and clinical based study on four passages of COVID-19 patients: intervention at asymptomatic period contributes to early recovery. BMC Infect Dis. (2020) 20:855. doi: 10.1186/s12879-020-05570-x

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. (2020) 25:2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Shrestha LB, Pokharel K. Standard operating procedure for specimen collection, packaging and transport for diagnosis of SARS-COV-2. JNMA J Nepal Med Assoc. (2020) 58:627–9. doi: 10.31729/jnma.5260

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. (2020) 395:507–13. doi: 10.1016/S0140-6736(20)30211-7

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. (2020) 104:246–51. doi: 10.1016/j.jhin.2020.01.022

PubMed Abstract | CrossRef Full Text | Google Scholar

42. van Doremalen N, Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. (2020) 382:1564–7. doi: 10.1101/2020.03.09.20033217

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Guo Z-D, Wang Z-Y, Zhang S-F, Li X, Li L, Li C, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerg Infect Dis. (2020) 26:1583–91. doi: 10.3201/eid2607.200885

PubMed Abstract | CrossRef Full Text

44. Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. (2020) 26:1–4. doi: 10.1038/s41591-020-0817-4

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. (2020) 21:100331. doi: 10.1016/j.eclinm.2020.100331

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Kuang M, Zheng L, Li C, Sheng L, Qi M, Deng H, et al. Management of a “suspected ward” in a COVID-19 designated hospital in Wuhan. Medicine. (2020) 99:e22720. doi: 10.1097/MD.0000000000022720

PubMed Abstract | CrossRef Full Text | Google Scholar

47. National Health Commission of the People's Republic of China. Medical Administration and Medical Authority (2020). Available online at: http://www.nhc.gov.cn/xcs/yqfkdt/202001/b91fdab7c304431eb082d67847d27e14.shtml (accessed March 4, 2020). [in Chinese]

48. Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J Med Virol. (2021) 93:456–62. doi: 10.1002/jmv.26259

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Temiz MZ, Dincer MM, Hacibey I, Yazar RO, Celik C, Kucuk SH, et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: a cross-sectional, pilot study. Andrologia. (2021) 53:e13912. doi: 10.1111/and.13912

PubMed Abstract | CrossRef Full Text | Google Scholar